Gilenya – What it is, How does it work? and What you should know of this (New) Oral medication
The National MS Society and MS Learn Online present… Two new Feature Presentations: Gilenya: What is it and How Does it…
Novartis to help MS patients pay for Gilenya
Highlights of the important and interesting in the world of healthcare: Novartis to pay for Gilenya. Novartis will pay out-of-pocket costs…
Stuart Schlossman
Novartis MS Program Guides Patients to New Pill, Covers Out-of-Pocket Cost
By Michelle Fay Cortez – Oct 4, 2010 8:57 AM ET Novartis AG will pay out-of-pocket costs for non-Medicare patients who use the company’s…
Stuart Schlossman
Gilenya, previously referred to as compound “FTY720”, (Fingolimod) will be available soon
The information found here is in this weeks edition of the MSFYi newsletter provided by the MS Foundation The first…
Stuart Schlossman
Information on Gilenya (TM), the first oral medication for MS
What to expect if planning to try Gilenya By Cherie C. Binns RN BS MSCN If you have been waiting…
Stuart Schlossman
FDA Approves Gilenya (Fingolimod-FTY720) – First Oral Disease-Modifying Therapy for Relapsing MS – Expected to be available by prescription in coming weeks
Sep 22, 2010 The U.S. Food and Drug Administration has approved fingolimod capsules (Gilenya,™ Novartis International AG) for reducing the…
Stuart Schlossman
BREAKING MS NEWS: Novartis Gets FDA Approval For Multiple Sclerosis Drug Gilenya
Sept 22, 2010 – 4:30am (RTTNews) – Novartis AG (NVS: News ) Wednesday announced that the US Food and Drug Administration approved the oral multiple…
Stuart Schlossman
Oral Laquinimod Demonstrated Sustained Efficacy and Safety in Patients with Multiple Sclerosis
September 20, 2010 “The results from this extension study confirm the balanced efficacy, safety, and tolerability profile seen with laquinimod…
Stuart Schlossman
Novartis International AG: Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy
Fri Sep 10, 2010 1:16am EDT Novartis International AG / Novartis announces Russian regulatory approval for Gilenya, a once-daily oral…
Stuart Schlossman
The Pros and Cons of Gilenya (Gilenia) (FTY720) – the first Oral medication for MS that will soon be FDA approved
For those that know me (Stuart Schlossman), they know that I often say, “there are pros and cons (positives &…
Stuart Schlossman
